Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient

Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient

This study reports the first patient treatment for cutaneous malignant melanoma using a linear accelerator-based boron neutron capture therapy (BNCT) system. A single-center open-label phase I clinical trial had been conducted using the system since November 2019. A patient with a localized node-neg...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hiroshi Igaki, Satoshi Nakamura, Naoya Yamazaki, Tomoya Kaneda, Mihiro Takemori, Tairo Kashihara, Naoya Murakami, Kenjiro Namikawa, Tetsu Nakaichi, Hiroyuki Okamoto, Kotaro Iijima, Takahito Chiba, Hiroki Nakayama, Ayaka Nagao, Madoka Sakuramachi, Kana Takahashi, Koji Inaba, Kae Okuma, Yuko Nakayama, Kazuaki Shimada, Hitoshi Nakagama, Jun Itami
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2023-10-01
coleção:Frontiers in Oncology
Assuntos:
boron neutron capture therapy (BNCT)
malignant melanoma
linear accelerator-based BNCT system
solid-state Li target
acral malignant melanoma
first treatment
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2023.1272507/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1272507/full

Registros relacionados